SASO Cosmetic Packaging新规：Plant Extracts Require Migration & Light Stability Tests from May 2026

Starting 1 May 2026, the Saudi Standards, Metrology and Quality Organization (SASO) will enforce new requirements for cosmetic packaging containing plant extracts—such as aloe vera, centella asiatica, and niacinamide derivatives. These rules directly impact exporters and suppliers of infant skincare packaging (e.g., baby gear & strollers kits) and skincare OEM products entering the Saudi market.

Event Overview

Effective 1 May 2026, SASO mandates that all cosmetic packaging materials containing plant-derived ingredients—including tubes, vacuum bottles, and dropper bottles—must pass two specific technical assessments: (1) food-contact material migration testing per EU Regulation (EC) No. 10/2011, and (2) accelerated light stability validation per ISO 11341:2023. Non-compliant products will be rejected at Riyadh Customs.

Industries Affected

Direct Exporters & Trading Companies

These entities face immediate customs clearance risk for shipments arriving in Saudi Arabia after 1 May 2026. Rejection at port means delayed revenue, storage costs, and potential rework or destruction of consignments—especially for time-sensitive infant skincare packaging lines.

Raw Material & Component Suppliers

Suppliers of plastic resins, laminates, or coated aluminum used in tubes and dropper bottles must now verify compatibility with plant extracts under migration and photostability conditions. Previously acceptable base materials may require reformulation or additional certification documentation.

Contract Manufacturers & Skincare OEMs

OEM facilities producing private-label or white-label skincare products for Middle Eastern brands must integrate new test protocols into their packaging qualification process. This adds lead time and validation cost before batch release—particularly for formulations using high-concentration botanical actives.

Distribution & Logistics Providers

Third-party logistics providers handling cosmetic imports into Saudi Arabia need updated compliance checklists. Documentation verification—including test reports referencing EC No. 10/2011 and ISO 11341:2023—will become mandatory pre-clearance steps at Riyadh Customs.

Key Focus Areas & Recommended Actions

Monitor official SASO implementation guidance

SASO has not yet published detailed transition timelines, accepted test lab criteria, or exemptions (e.g., for low-concentration extracts). Companies should track updates via the SASO e-Portal and official gazettes, especially through Q1 2026.

Prioritize high-risk SKUs for early validation

Focus initial testing on packaging formats most commonly used in infant skincare (e.g., squeezable PE/ALU laminated tubes) and high-value OEM contracts where plant extracts exceed 0.5% w/w. Avoid blanket testing; instead align validation scope with actual product composition and dosage form.

Distinguish policy signal from operational enforcement

The regulation takes effect 1 May 2026—but customs enforcement may begin gradually. Observably, early rejections are likely limited to high-volume or previously non-compliant importers. Still, documentation readiness—not just product readiness—should be confirmed by March 2026.

Update supplier agreements and QC checklists

Revise procurement terms with packaging vendors to include explicit clauses on migration and light stability compliance. Integrate test report submission deadlines and format requirements (e.g., accredited lab seals, full extractant lists) into incoming goods inspection protocols.

Editorial Perspective / Industry Observation

This requirement is better understood as a regulatory signal than an immediate operational disruption—yet one with clear enforcement teeth. Analysis shows SASO is aligning cosmetic packaging oversight more closely with food-contact safety frameworks, reflecting growing regional emphasis on ingredient-package interaction risks. From an industry perspective, it signals a broader shift toward requiring stability data not just for formulations, but for their delivery systems—especially where bioactive botanicals are involved. Continuous monitoring remains essential, as interpretation of ‘plant extract’ scope (e.g., hydroglycolic vs. oleoresinous forms) and acceptance of alternative standards (e.g., US FDA 21 CFR 175–177) is still pending clarification.

Conclusion
This update marks a formal step toward stricter functional safety validation for cosmetic packaging in Saudi Arabia. It does not represent a broad-based ban or sudden market barrier—but rather a targeted technical threshold tied to specific material–ingredient combinations. Current interpretation should emphasize preparedness over panic: companies with structured quality agreements, traceable packaging sourcing, and proactive test planning are best positioned to maintain continuity. The regulation is less about restricting trade and more about elevating baseline evidence requirements for package integrity in sensitive applications.

Information Sources
Primary source: Saudi Standards, Metrology and Quality Organization (SASO), official regulatory notice effective 1 May 2026.
Note: Implementation details—including recognized laboratories, transitional provisions, and definitions of ‘plant extract’ thresholds—remain under observation and are subject to further SASO communication.